Company intelligence / Profile preview

中诺凯琳医药发展

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Beijing Zhongnuo Kailin Pharmaceutical Development is a professional contract research organization (CRO) based in Beijing, China, specializing in pharmaceutical research and development services. Founded in 2004, the company provides comprehensive technical solutions including drug synthesis, formulation development, and quality standard establishment. It focuses on assisting pharmaceutical enterprises with the registration and development of both generic and innovative drugs within the Chinese market. Zhongnuo Kailin is recognized for its expertise in navigating NMPA regulatory requirements and facilitating technology transfers. The organization serves as a critical link between laboratory-scale research and commercial-scale pharmaceutical production.

Modalities: Small molecule
Industry: Drug Discovery Services

Beyond the preview

Go deeper on 中诺凯琳医药发展.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 中诺凯琳医药发展.

Explore the full profile